Amy C. Doty
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Ophthalmology top 10%
- Glaucoma and retinal disorders
Papers in
-
- Advanced Drug Delivery Systems 4
- Drug Solubulity and Delivery Systems 3
-
- RNA Interference and Gene Delivery 2
- Viral Infectious Diseases and Gene Expression in Insects 1
- Protein purification and stability 1
- Co-authors
- Stephanie Choi (4 shared papers)Steven P. Schwendeman (3 shared papers)Karl Olsen (3 shared papers)Keiji Hirota (3 shared papers)Rose Ackermann (3 shared papers)Yan Wang (3 shared papers)Wen Qu (3 shared papers)Bryce Chiang (1 shared paper)
- Journals
- Journal of Controlled Release (3 papers)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Journal of Pharmaceutical Sciences (1 paper)Chemistry and Physics of Lipids (1 paper)
- Partner nations
- United States
In The Last Decade
Amy C. Doty
8 papers receiving 336 citations
Peers
Comparison fields: 5 of 76
- Pharmaceutical Science 179
- Ophthalmology 48
- Molecular Medicine 27
- Biomaterials 67
- Public Health, Environmental and Occupational Health 40
Countries citing papers authored by Amy C. Doty
This map shows the geographic impact of Amy C. Doty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C. Doty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C. Doty more than expected).
Fields of papers citing papers by Amy C. Doty
This network shows the impact of papers produced by Amy C. Doty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C. Doty. The network helps show where Amy C. Doty may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy C. Doty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 79 | |
| 2 | 2016 | 74 | |
| 3 | 2016 | 73 | |
| 4 | 2016 | 41 | |
| 5 | 2011 | 30 | |
| 6 | 2016 | 26 | |
| 7 | 2020 | 10 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 1 |
About Amy C. Doty
Amy C. Doty is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Cellular and Molecular Neuroscience and Biological Psychiatry, having authored 9 papers that have together received 340 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Drug Solubulity and Delivery Systems (3 papers), RNA Interference and Gene Delivery (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Protein purification and stability (1 paper), Polymer Surface Interaction Studies (1 paper) and Ocular Surface and Contact Lens (1 paper). The work is most often cited by research in Pharmaceutical Science (179 citations), Ophthalmology (48 citations), Molecular Medicine (27 citations), Biomaterials (67 citations) and Public Health, Environmental and Occupational Health (40 citations). Amy C. Doty has collaborated with scholars based in United States. Frequent co-authors include Stephanie Choi, Steven P. Schwendeman, Karl Olsen, Keiji Hirota, Rose Ackermann, Yan Wang, Wen Qu, Bryce Chiang, Steven P. Schwendeman and Hans E. Grossniklaus. Their work appears in journals such as Journal of Controlled Release, European Journal of Pharmaceutics and Biopharmaceutics, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmaceutical Sciences and Chemistry and Physics of Lipids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.